<!DOCTYPE html>
<html>
<head>
<link rel="stylesheet" href="/common/css/style.css" />
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<title>Comprehensive Cancer Information - National Cancer
	Institute</title>
</head>
<body>
	<div style='width: 1000px; margin-left: auto; margin-right: auto;'>
		<div id="wrapper">
			<div id="logos">
				<div id="left">
					<a href="http://www.cancer.gov" target="_blank"><img
						src="/common/images/nci.jpg" width="286" height="40" border="0"
						alt="National Cancer Institute" title="National Cancer Institute" /></a>
				</div>
				<div id="right">
					<a href="http://www.cancer.gov" target="_blank"><img
						src="/common/images/nih.jpg" width="322" height="40" border="0"
						alt="at the National Institutes of Health"
						title="at the National Institutes of Health" /></a>
				</div>
			</div>
		</div>
	</div>
	<div id="landing-blockcontent">
		<h3 class="tools-owner-title">DCEG Analysis Tools</h3>
		<div class="tools-section">
			<h4>Biomarker Risk Stratification Tools</h4>
			<p>This toolset estimates risk stratification from early
				biomarker data and includes math and strategies to advance
				biomarkers or other risk measures identified case-control studies to
				clinical or public health applications. The toolset will show
				quantities for which people's intuition is poor, such as need for
				high specificity for a single marker of a rare disease to improve
				management by some serious intervention. The toolset will allow to
				evaluate the feasibility of biomarkers called promising before they
				get press office attention; investigators spend efforts on hopeless
				pursuit; wasteful. unethical clinical testing begins. Thus, using
				these strategies will allow focusing on the most promising markers
				early on, making specific improvements if required, or abandoning
				markers that are most likely to fail.</p>
			<ul>
				<li><a href="/meanstorisk">The Means To Risk Stratification
						Tool</a></li>
				<li><a href="/bc/">Biomarker Comparison Tool</a></li>
				<li><a href="/riskStratAdvanced/">Risk Stratification
						Advanced Options Tool</a></li>
			</ul>
		</div>
		<div class="tools-section">
			<h4>Age Period Cohort Analysis Tools</h4>
			<p>Age-Period-Cohort analysis identifies patterns in cancer
				incidence or mortality rates from population-based Count (numerator)
				and Population (denominator) data. Often the data come from a Cancer
				Registry (e.g., SEER) in the form of a table showing the numbers of
				cancer cases or cancer deaths (counts) and corresponding
				person-years at risk (population) for particular age groups and
				calendar time periods. This toolset provides a comprehensive
				solution to age-period-cohort analysis for cancer endpoints
				in defined populations and time periods.
			<ul>
				<li><a href="/apc">Age Period Cohort (APC) Web Tool</a></li>
			</ul>
		</div>
	</div>
	<!-- main -->

	<div id="portal-footer">
		<div class="footerLinks">
			<a href="http://www.cancer.gov/" title="Home">Home</a>&nbsp;&nbsp;|&nbsp;&nbsp;
			<a href="http://www.cancer.gov/global/web/policies" title="Policies">Policies</a>&nbsp;&nbsp;|&nbsp;&nbsp;
			<a href="http://www.cancer.gov/global/web/policies/accessibility"
				title="Accessibility">Accessibility</a>&nbsp;&nbsp;|&nbsp;&nbsp; <a
				href="http://cancer.gov/global/viewing-files" target="_blank"
				title="Viewing Files">Viewing Files</a>&nbsp;&nbsp;|&nbsp;&nbsp; <a
				href="http://www.cancer.gov/global/web/policies/foia" title="FOIA">FOIA</a><br />
			<br /> <a href="http://www.dhhs.gov/">Department of Health and
				Human Services</a>&nbsp;&nbsp;|&nbsp;&nbsp; <a
				href="http://www.nih.gov/">National Institutes of Health</a>&nbsp;&nbsp;|&nbsp;&nbsp;
			<a href="http://www.cancer.gov/">National Cancer Institute</a>&nbsp;&nbsp;|&nbsp;&nbsp;<a
				href="http://www.usa.gov/">USA.gov</a>
		</div>
		<br /> <br /> NIH...Turning Discovery Into Health<sup>&reg;</sup>
	</div>
</body>
</html>
